Microbial structures

Microbial structures encompass the diverse physical and molecular components of microorganisms, including bacteria, viruses, fungi, and parasites, that are essential for their survival, replication, and pathogenicity. These structures include the bacterial cell wall (peptidoglycan), fungal cell membranes (ergosterol), viral capsids, and microbial ribosomes (StatPearls, Antibiotics, 2023). In pharmacology, these structures serve as primary targets for antimicrobial agents, which exploit the biochemical differences between microbial and host cells to achieve selective toxicity (NIH, Antimicrobial Resistance, 2022). For example, beta-lactam antibiotics target the synthesis of the bacterial cell wall, a structure absent in human cells, while other agents target the unique machinery of the microbial ribosome. Selective targeting allows for the eradication of pathogens with minimal impact on human physiology. However, the clinical utility of targeting these structures is increasingly threatened by the emergence of antimicrobial resistance, where microbes evolve to bypass or modify these targets (Nature Reviews Microbiology, The challenge of antimicrobial resistance, 2021). Additionally, many drugs targeting microbial structures can inadvertently affect the host's commensal microbiome, leading to dysbiosis and secondary infections like Clostridioides difficile. Understanding the specific molecular architecture of these structures remains a cornerstone of infectious disease research and the development of new therapeutic classes.

Other names

Pathogen-associated molecular patternsPAMPsMicrobial componentsBacterial cell wallViral capsidFungal cell wallMicrobial ribosome

Inhibition of cell wall synthesis, inhibition of protein synthesis, disruption of membrane integrity, and inhibition of nucleic acid replication.